218 related articles for article (PubMed ID: 15801847)
1. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
[TBL] [Abstract][Full Text] [Related]
2. N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography.
Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
Bioorg Med Chem Lett; 2004 Apr; 14(8):1927-30. PubMed ID: 15050629
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity.
Kikuchi T; Okamura T; Zhang MR; Fukushi K; Irie T
Synapse; 2010 Mar; 64(3):209-15. PubMed ID: 19862687
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PET.
Mori T; Sun LQ; Kobayashi M; Kiyono Y; Okazawa H; Furukawa T; Kawashima H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2009 Feb; 36(2):155-62. PubMed ID: 19217527
[TBL] [Abstract][Full Text] [Related]
5. [Imaging of brain acetylcholinesterase activity in dementias and extrapyramidal disorders].
Shinotoh H
Rinsho Shinkeigaku; 2007 Nov; 47(11):822-5. PubMed ID: 18210807
[TBL] [Abstract][Full Text] [Related]
6. PET probes for imaging brain acetylcholinesterase.
Kikuchi T; Okamura T; Zhang MR; Irie T
J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
[TBL] [Abstract][Full Text] [Related]
7. N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo.
Zhang MR; Furutsuka K; Maeda J; Kikuchi T; Kida T; Okauchi T; Irie T; Suzuki K
Bioorg Med Chem; 2003 Jun; 11(12):2519-27. PubMed ID: 12757720
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity.
Snyder SE; Gunupudi N; Sherman PS; Butch ER; Skaddan MB; Kilbourn MR; Koeppe RA; Kuhl DE
J Cereb Blood Flow Metab; 2001 Feb; 21(2):132-43. PubMed ID: 11176278
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.
Willis PG; Pavlova OA; Chefer SI; Vaupel DB; Mukhin AG; Horti AG
J Med Chem; 2005 Sep; 48(18):5813-22. PubMed ID: 16134948
[TBL] [Abstract][Full Text] [Related]
10. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
[TBL] [Abstract][Full Text] [Related]
11. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE
Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130
[TBL] [Abstract][Full Text] [Related]
12. Preliminary studies of acetylcholinesterase activity in the rat brain using N-phenylferrocenecarboxamide labelled by the technetium-99m.
Mejri N; Said NM; Guizani S; Essouissi I; Saidi M
Nucl Med Biol; 2013 May; 40(4):561-6. PubMed ID: 23465564
[TBL] [Abstract][Full Text] [Related]
13. Syntheses of carbon-11 labeled piperidine esters as potential in vivo substrates for acetylcholinesterase.
Nguyen TB; Snyder SE; Kilbourn MR
Nucl Med Biol; 1998 Nov; 25(8):761-8. PubMed ID: 9863564
[TBL] [Abstract][Full Text] [Related]
14. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
[TBL] [Abstract][Full Text] [Related]
15. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
[TBL] [Abstract][Full Text] [Related]
16. Effect of radiolabeled metabolite elimination from the brain on the accuracy of cerebral enzyme activity estimation using positron emission tomography with substrate tracers.
Ohya T; Okamura T; Nagai Y; Fukushi K; Irie T; Suhara T; Zhang MR; Fukumura T; Kikuchi T
Neuroimage; 2011 Jun; 56(3):1105-10. PubMed ID: 21324368
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and biological evaluation of (18)F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl)propan-1-ones for in vivo mapping of acetylcholinesterase.
Choe YS; Oh S; Shim I; Naruto S; Chi DY; Kim SE; Lee K; Choi Y; Kim B
Nucl Med Biol; 2000 Apr; 27(3):263-7. PubMed ID: 10832083
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preliminary evaluation of [(18)F]-fluoro-(2S)-Exaprolol for imaging cerebral beta-adrenergic receptors with PET.
Stephenson KA; van Oosten EM; Wilson AA; Meyer JH; Houle S; Vasdev N
Neurochem Int; 2008 Nov; 53(5):173-9. PubMed ID: 18675864
[TBL] [Abstract][Full Text] [Related]
19. Cerebral acetylcholinesterase imaging: development of the radioprobes.
Kikuchi T; Okamura T; Fukushi K; Takahashi K; Toyohara J; Okada M; Zhang MR; Irie T
Curr Top Med Chem; 2007; 7(18):1790-9. PubMed ID: 17979787
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
